Building on results of the landmark SELECT trial, SCORE shows cardiovascular (CV) risk reduction with use of semaglutide 2.4 mg in a real-world environment 1 SCORE is a retrospective ...

As it hits a 13-year high, silver bulls online are trying to arrange a new silver squeeze But experts warn it’s prudent to be sceptical about co-ordinated short squeezes More moderate forecasters ...

Amid rising concerns about benzodiazepines, some patients who try to quit are suffering extreme anxiety, memory loss and intense physical pain.